Supported by previous funding of this project, we have demonstrated suggestive linkage for schizophrenia susceptibility on chromosome 6p22-p24 in the 270 multiplex families from the Irish Study of High Density Schizophrenia Families (ISHDSF). These findings have been supported by data from numerous independent samples of multiplex schizophrenia families using different study designs, and by a collaborative multicenter study. Furthermore, we recently identified a set of SNP markers in a novel gene that give highly significant evidence of association with schizophrenia susceptibility in this sample and identified this gene (dystrobrevin binding protein 1, DTNBP1) as the human ortholog of mouse dysbindin or Dtnbp1) Association with this gene has been replicated by a number of groups using different study designs. Analyses of the current data show significant excess transmission of a haplotype of 8 markers in both the Irish pedigrees and in a sample of 79 sib-pair families from Germany and Israel and 128 trios from Germany. The specific overtransmitted haplotype is different in these two samples. None of the SNP variants so far tested have any predicted functional role. We argue below that current data strongly support two hypotheses: 1) that the haplotype region contains pathogenic variant(s) and 2) that these variant(s) impact on schizophrenia liability. The identification of the relatively rare Irish high risk haplotype (HRH), a more common overtransmitted haplotype in the German sample, and the overall haplotype block structure of the region allow us to define specific-haplotype-based cases in both samples for screening and allow us to map variation back to specific haplotypes. We also argue below that collaborative work in these 2 samples yields two benefits: additional power both for variant detection and subsequent analysis and an essential control group for such specific-haplotype-based variation screening. In this competitive renewal, we request 5 further years of support with the primary goals of identifying these pathogenic variant(s) and relating them to the biology of the gene, gene product and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH041953-13
Application #
6720928
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Lehner, Thomas
Project Start
1986-12-01
Project End
2009-03-31
Budget Start
2004-07-13
Budget End
2005-03-31
Support Year
13
Fiscal Year
2004
Total Cost
$600,658
Indirect Cost
Name
Virginia Commonwealth University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Chen, Qiaolin; Sugar, Catherine A; Weiss, Robert E (2018) A Bayesian confirmatory factor model for multivariate observations in the form of two-way tables of data. Stat Med 37:1696-1710
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Han, Jun; Walters, James T R; Kirov, George et al. (2016) Gender differences in CNV burden do not confound schizophrenia CNV associations. Sci Rep 6:25986
Green, E K; Rees, E; Walters, J T R et al. (2016) Copy number variation in bipolar disorder. Mol Psychiatry 21:89-93
Franke, Barbara; Stein, Jason L; Ripke, Stephan et al. (2016) Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci 19:420-431
Edwards, Alexis C; Bigdeli, Tim B; Docherty, Anna R et al. (2016) Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. Schizophr Bull 42:279-87
Docherty, Anna R; Bigdeli, T Bernard; Edwards, Alexis C et al. (2015) Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT. Schizophr Res 164:181-6
Bigdeli, T Bernard; Bacanu, Silviu-Alin; Webb, Bradley T et al. (2014) Molecular validation of the schizophrenia spectrum. Schizophr Bull 40:60-5
Rees, E; Kirov, G; Sanders, A et al. (2014) Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 19:37-40
Heron, Elizabeth A; Cormican, Paul; Donohoe, Gary et al. (2014) No evidence that runs of homozygosity are associated with schizophrenia in an Irish genome-wide association dataset. Schizophr Res 154:79-82

Showing the most recent 10 out of 148 publications